Custom Antibody Market Size, Share, Industry Trends and Forecast to 2030

Custom Antibody Market Size & CAGR in 2021

The global custom antibody market is anticipated to reach a value of USD 3.21 billion by the end of 2021, with a Compound Annual Growth Rate (CAGR) of 8.4% from 2021 to 2027. The increasing demand for personalized medicine and advancements in biotechnology are driving the growth of the custom antibody market.

COVID-19 Impact on the Custom Antibody Market

The COVID-19 pandemic has had a significant impact on the custom antibody market. With the rise in research and development activities to develop diagnostic kits and vaccines for COVID-19, the demand for custom antibodies has surged. Many companies in the biotechnology and pharmaceutical sectors have shifted their focus towards developing antibodies to combat the virus, leading to a boost in the custom antibody market.

Custom Antibody Dynamics

Custom antibodies are antibodies that are specifically designed and produced for a particular target antigen. They play a crucial role in various applications such as research, diagnostics, and therapeutics. The rising prevalence of chronic diseases, advancements in proteomics and genomics, and the increasing demand for personalized medicine are some of the key factors driving the growth of the custom antibody market.

Segments and Related Analysis

Antibody Type Segmentation:

- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies

Among these segments, monoclonal antibodies are expected to dominate the custom antibody market due to their specificity and efficacy in targeting particular antigens. The increasing adoption of monoclonal antibodies in cancer therapy and autoimmune diseases is driving the growth of this segment.

Application Segmentation:

- Research
- Diagnostics
- Therapeutics

The diagnostics segment is anticipated to witness significant growth in the custom antibody market, owing to the increasing use of custom antibodies in diagnostic tests for various diseases and conditions. Custom antibodies play a crucial role in detecting specific antigens and markers in diagnostic assays.

By Region Analysis

North America

- The North American region is expected to hold a substantial market share in the custom antibody market due to the presence of key market players, technological advancements, and increased funding for research and development activities.

Europe

- Europe is anticipated to witness significant growth in the custom antibody market, driven by the increasing prevalence of chronic diseases and the rising demand for personalized medicine in the region.

Asia Pacific

- The Asia Pacific region is projected to experience rapid growth in the custom antibody market, supported by the expanding biotechnology and pharmaceutical sectors, along with the increasing investments in healthcare infrastructure.

Key Market Players and Competitive Landscape

Some of the key players in the custom antibody market include Thermo Fisher Scientific Inc., Abcam plc, Merck KGaA, Bio-Rad Laboratories, Inc., GenScript Biotech Corporation, and others. These companies are actively engaged in product development, collaborations, and strategic partnerships to enhance their market presence and expand their product offerings.

Recent Happenings in the Custom Antibody Market

- In April 2021, Thermo Fisher Scientific Inc. announced the launch of a new range of custom antibody services to meet the growing demand for personalized antibodies in research and diagnostics.

- In June 2021, Abcam plc entered into a partnership with a leading biopharmaceutical company to develop custom antibodies for a novel therapeutic target in oncology.

- In August 2021, Merck KGaA introduced a new custom antibody platform that enables researchers to design and generate antibodies tailored to their specific research needs.

These recent developments signify the growing importance of custom antibodies in various scientific and medical applications and highlight the dynamic nature of the custom antibody market.